RNF216 Rabbit anti-Human, Polyclonal, Invitrogen™
Rabbit Polyclonal Antibody
Manufacturer: Invitrogen PA141317
Suggested positive control: human spleen protein, antigen standard for RNF216 (transient overexpression lysate), human lung protein, human ovary protein, human pancreas protein, human skeletal muscle protein, human heart protein, human kidney protein, human liver protein, human brain protein, human brain tissue, heart tissue, kidney tissue, liver tissue, lung tissue, ovary tissue, pancreas tissue, small intestine tissue, skeletal muscle tissue, spleen tissue, human small intestine protein.Principal Names: TRIAD3; E3-Ubiquitin Ligase TRIAD3; U7I1; ZIN; Zinc finger protein inhibiting NF-kappaB; Ubiquitin conjugating enzyme 7 interacting protein 1; UBCE7IP1; Official Gene Symbol: TRIAD3 Gene ID: 54476 (Human) Gene Map Locus: 7p22.1 (Human) TRIADs are novel zinc finger proteins characterized by the presence of Cysteine rich TRIAD domain consisting of DRIL motif flanked by 2 RING fingers. TRIAD3, a 56KDa protein, is a novel member of this family. It contains 4 RLD domains in the centre and a proline-rich domain at the C-terminus. Localized in the cytoplasm, it interacts with RIP and inhibits TNF and IL1-induced NF-kappaB activation pathways. Reports suggest TRIAD3 acts as an E3-ubiquitin-protein ligase and promotes ubiquitination and degradation of TLR4 and TLR9, thereby regulating TLR signaling. It also interacts with HIV type I Vif protein and interferes in the early events of HIV-1 replication.
|Synthetic peptide corresponding to residues 350-400 of human TRIAD3A.|
|PBS with 0.2% gelatin and 0.05% sodium azide|
|TRIAD3, U7I1, UBCE7IP1, ZIN|
|Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.Ok